These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 20944153)
1. Novel chemoradiosensitizers for cancer therapy. Page P; Yang LX Anticancer Res; 2010 Sep; 30(9):3675-82. PubMed ID: 20944153 [TBL] [Abstract][Full Text] [Related]
2. New and emerging radiosensitizers and radioprotectors. Spalding AC; Lawrence TS Cancer Invest; 2006; 24(4):444-56. PubMed ID: 16777698 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs. Chen AY; Chou R; Shih SJ; Lau D; Gandara D Crit Rev Oncol Hematol; 2004 May; 50(2):111-9. PubMed ID: 15157660 [TBL] [Abstract][Full Text] [Related]
4. New radiosensitizing regimens, drugs, prodrugs, and candidates. Vallerga AK; Zarling DA; Kinsella TJ Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960 [TBL] [Abstract][Full Text] [Related]
5. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. Coughlin CT; Richmond RC Semin Oncol; 1989 Aug; 16(4 Suppl 6):31-43. PubMed ID: 2669136 [TBL] [Abstract][Full Text] [Related]
6. Modification of radiotherapy by radiosensitizers and cancer chemotherapeutic agents. II. Cancer chemotherapeutic agents. Looney WB; Hopkins HA Semin Oncol; 1989 Jun; 16(3):176-9. PubMed ID: 2658081 [No Abstract] [Full Text] [Related]
10. Motexafin gadolinium: a novel radiosensitizer for brain tumors. Francis D; Richards GM; Forouzannia A; Mehta MP; Khuntia D Expert Opin Pharmacother; 2009 Sep; 10(13):2171-80. PubMed ID: 19640206 [TBL] [Abstract][Full Text] [Related]
11. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers. Coleman CN Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080 [No Abstract] [Full Text] [Related]
12. [Perspectives in biological modulation of radiotherapy]. Deutsch E; Huguet F Bull Cancer; 2005 Jan; 92(1):90-6. PubMed ID: 16123013 [TBL] [Abstract][Full Text] [Related]
13. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Miller AR; Pisters PW; Lee JE; Janjan NA; Abbruzzese JL; Evans DB Hepatogastroenterology; 1998; 45(21):624-33. PubMed ID: 9684107 [TBL] [Abstract][Full Text] [Related]
14. Motexafin gadolinium: a clinical review of a novel radioenhancer for brain tumors. Khuntia D; Mehta M Expert Rev Anticancer Ther; 2004 Dec; 4(6):981-9. PubMed ID: 15606327 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors and demethylating agents: clinical development of histone deacetylase inhibitors for cancer therapy. Piekarz RL; Sackett DL; Bates SE Cancer J; 2007; 13(1):30-9. PubMed ID: 17464244 [TBL] [Abstract][Full Text] [Related]
16. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse. Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy. Dunst J; Haensgen G Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401 [TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of poly(ADP-ribose) polymerase in cancer. Plummer ER Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340 [TBL] [Abstract][Full Text] [Related]